1 basic requirements
软件测试用例编写规范
软件测试用例编写规范测试用例编写规范{项目名称}测试用例文件状态: 文件标识:[ ] 草稿当前版本:[ ] 正式发布作者:[ ] 正在修改完成日期:ultrasound 3 months; superficial vascular Sonography 1 month; Interventional Ultrasound 1 month. Nuclear Imaging: PET/CT 6 months; SPECT 4 months and radionuclide therapy for 2 months. Three, training contents and requirements (a) the 1th to 12th month (phase I) 1. purpose rotary system knowledge and understanding of the basic theory, basic skills and basic operations, master of the discipline involved in common diseases and frequently-occurring diseases of the basic principles of diagnosis and treatment. Understanding of these professional groups work programs, content and the related clinical knowledge. 2. basic requirements (1) Department of Radiology: the mastery: the basic theory of x-ray, including general radiology, CT and MRI Imaging principle and technique. Writing principles of radiographic diagnostic report and complete schedule 1 to the diseases, the number of cases of report writing, requiring trainees diagnostic report written at least 50 a week. Familiar: principles of radiographic methods of observation and analysis,diagnosis, understanding of x-ray diagnostic value and clinical application of limits. About: x-ray radiography, CT, and MRI examination methods of operation. Disease and case requirements: System (inspection) disease/operation name (times) (?) nervous system (dominated by CT and MRI) 15 15 15 brain brain tumor cerebral infarction of cerebral hemorrhage outside the ... ? complete schedule 3 to the technical operation and the writing of the report. Basic skills requirements: disease/operation name cases (times) number (?) actual demonstrates Ray protection principles 5 times radionuclide generator leaching drug operation 5 times shows trace agent of Mark 5 times 131I sucking iodine rate determination 5 times kidney function (kidney figure) determination and the report writing版本历史版本/状态作者参与者起止日期备注ultrasound 3 months; superficial vascular Sonography 1 month; Interventional Ultrasound 1 month. Nuclear Imaging: PET/CT 6 months; SPECT 4 months and radionuclide therapy for 2 months. Three, training contents and requirements (a) the 1th to 12th month (phase I) 1. purpose rotary system knowledge and understanding of the basic theory, basic skills and basic operations, master of the discipline involved in common diseases and frequently-occurring diseases of the basic principles of diagnosis and treatment. Understanding of these professional groups work programs, content and the related clinical knowledge. 2. basic requirements (1) Department of Radiology: the mastery: the basic theoryof x-ray, including general radiology, CT and MRI Imaging principle and technique. Writing principles of radiographic diagnostic report and complete schedule 1 to the diseases, the number of cases of report writing, requiring trainees diagnostic report written at least 50 a week. Familiar: principles of radiographic methods of observation and analysis, diagnosis, understanding of x-ray diagnostic value and clinical application of limits. About: x-ray radiography, CT, and MRI examination methods of operation. Disease and case requirements: System (inspection) disease/operation name (times) (?) nervous system (dominated by CT and MRI) 15 15 15 brain brain tumor cerebral infarction of cerebral hemorrhage outside the ... ? complete schedule 3 to the technical operation and the writing of the report. Basic skills requirements: disease/operation name cases (times) number (?) actual demonstrates Ray protection principles 5 times radionuclide generator leaching drug operation 5 times shows trace agent of Mark 5 times 131I sucking iodine rate determination 5 times kidney function (kidney figure) determination and the report writing目录1. 概述 ..................................................................... .............................................................- 1 - 1.1目的 ..................................................................... ...........................................................- 1 - 1.2使用范围 ..................................................................... ....................................................- 1 - 1.3名词解释 ..................................................................... ....................................................- 1 - 2. 测试用例编写原则 ..................................................................... .......................................- 1 - 2.1系统性...................................................................... .......................................................- 1 - 2.2连贯性...................................................................... .......................................................- 1 - 2.3全面性...................................................................... .......................................................- 2 - 2.4正确性...................................................................... .......................................................- 2 - 2.5符合正常业务惯例 ..................................................................... .....................................- 2 - 2.6仿真性...................................................................... .......................................................- 2 - 2.7容错性(健壮性) .................................................................... ......................................- 2 - 3. 测试用例设计方法 ..................................................................... .......................................- 2 - 4. 测试用例编写规范 ..................................................................... .......................................- 4 - 4.1测试用例命名规则 ..................................................................... .....................................- 4 - 4.2测试用例编号规则 ..................................................................... .....................................- 4 - 4.3测试用例书写规则 ..................................................................... .....................................- 5 - 4.4测试用例编写流程 ..................................................................... ................................... - 10 - 5. 测试用例模板...................................................................... ............................................ - 11 - 5.1功能测试用例...................................................................... .......................................... - 11 - 5.2健壮性测试用例 ..................................................................... ....................................... - 13 - 5.3性能测试用例...................................................................... .......................................... - 14 - 5.4图形用户界面测试用例 ..................................................................... ............................ - 15 - 5.5 用户界面测试的检查表 ..................................................................... ........................... - 16 - 5.6信息安全性测试用例...................................................................... ............................... - 17 -ultrasound 3 months; superficial vascular Sonography 1 month; Interventional Ultrasound 1 month. Nuclear Imaging: PET/CT 6 months; SPECT 4 months and radionuclide therapy for 2 months. Three, training contents and requirements (a) the 1th to 12th month (phase I) 1. purpose rotary system knowledge and understanding of the basic theory, basic skills and basic operations, master of the discipline involved in common diseases and frequently-occurring diseases of the basic principles of diagnosis and treatment. Understanding of these professional groups work programs, content and the related clinical knowledge. 2. basic requirements (1) Department of Radiology: the mastery: the basic theory of x-ray, including general radiology, CT and MRI Imaging principle and technique. Writing principles of radiographic diagnostic report and complete schedule 1 to the diseases, the number of cases of report writing, requiring trainees diagnostic report written at least 50 a week. Familiar: principles of radiographic methods of observation and analysis, diagnosis, understanding of x-ray diagnostic value and clinical application of limits. About: x-ray radiography, CT, and MRI examination methods of operation. Disease and case requirements: System (inspection) disease/operation name (times) (?) nervous system (dominated by CT and MRI) 15 15 15 brain brain tumor cerebral infarction of cerebral hemorrhage outside the ... ? complete schedule 3 to the technical operation and the writing of the report. Basic skills requirements:disease/operation name cases (times) number (?) actual demonstrates Ray protection principles 5 times radionuclide generator leaching drug operation 5 times shows trace agent of Mark 5 times 131I sucking iodine rate determination 5 times kidney function (kidney figure) determination and the report writing测试用例编写规范1. 概述1.1目的统一测试用例编写的规范，为测试设计人员提供测试用例编写的指导，提高编写的测试用例的可读性，可执行性、合理性。
《公共建筑节能(绿色建筑)工程施工质量验收规范》DBJ50-234-2016
（ 7 ） 本 规 范 第 16.2.10 条 依 据 国 家 标 准 《 太 阳 能 供 热 采 暖 工 程 技 术 规 范 》 GB50495-2009 第 5.3.5 条的规定。
（8）本规范第 3.4.4 条为绿色建筑工程涉及的建筑环境与资源综合利用子分部工程 验收方式的规定。
本规范由重庆市城乡建设委员会负责管理，由重庆市建设技术发展中心（重庆市建 筑节能中心）、重庆市绿色建筑技术促进中心负责具体技术内容解释。在本规范的实施 过程中，希望各单位注意收集资料，总结经验，并将需要修改、补充的意见和有关资料 交重庆市建设技术发展中心（重庆市渝中区牛角沱上清寺路 69 号 7 楼，邮编：400015， 电话：023-63601374，传真：023-63861277），以便今后修订时参考。
建设部备案号： J13144-2015
DB
重庆市工程建设标准 DBJ50-234-2016Leabharlann 公共建筑节能（绿色建筑）工程
施工质量验收规范
Code for acceptance of energy efficient public building(green building) construction
（3）本规范第 1.0.4、3.1.2、11.2.4、22.0.6、22.0.7 条内容分别依据国家标准《建 筑节能工程施工质量验收规范》GB50411-2007 第 1.0.5、3.1.2 条、11.2.3、15.0.5、15.0.5 条等强制性条文要求。
医疗器械ivd安全有效的基本要求清单英文
Basic Requirements Checklist for Safety and Effectiveness of In Vitro Diagnostic (IVD) Medical Devices In vitro diagnostic (IVD) medical devices play a crucial role in healthcare by providing important information for the diagnosis, treatment, and monitoring of diseases. To ensure the safety and effectiveness of these devices, various regulatory bodies have established specific requirements that manufacturers must adhere to. This checklist outlines the fundamental requirements for the safety and effectiveness of IVD medical devices.1. Design and Development•The device design should be based on scientific principles and well-established technology.•The device should be able to perform its intended function accurately and reliably.•The design should consider appropriate measures for user safety, including ergonomic factors and minimizing potential hazards.•The device should take into account the needs of the target population and end-users.2. Analytical Performance•The device should have appropriate analytical sensitivity and specificity for the intended use.•It should be able to correctly identify and quantify the target analyte or biomarker.•The device should demonstrate acceptable precision and accuracy in test results.•The device should have appropriate limits of detection and quantification.3. Clinical Performance•The device should have clinical validity, i.e., it should provide accurate and reliable information for clinical decision-making.•It should demonstrate clinical sensitivity and specificity, by accurately identifying the presence or absence of a particular condition.•The device should be able to differentiate between various conditions or disease stages, when relevant.•The device should have appropriate positive and negative predictive values.4. Quality Management System•The manufacturer should have a comprehensive quality management system in place to ensure the consistent quality of the device.•The system should comply with applicable international standards, such as ISO 13485.•It should include procedures for risk management, design control, post-market surveillance, and complaint handling.•The manufacturer should regularly perform internal audits and assessments to maintain the effectiveness of the quality management system.5. Labeling and Instructions for Use•The device labeling should be clear, accurate, and comprehensive.•It should include essential information for the safe and effective use of the device, such as intended use, limitations, and precautions.•The instructions for use should be easy to understand and follow.•The labeling should provide information on storage, handling, and disposal of the device, when applicable.6. Post-Market Surveillance•The manufacturer should have a system in place to monitor the performance and safety of the device after it is placed on the market.•The system should include mechanisms for adverse event reporting, trend analysis, and corrective actions.•The manufacturer should actively collect and analyze data on device malfunction, user-related errors,and any known risks.•The post-market surveillance system should enable the manufacturer to take appropriate actions, such asproduct recalls or modifications, if necessary.7. Clinical Evaluation and Evidence•The manufacturer should conduct a comprehensive clinical evaluation of the device to assess its safety andperformance.•The evaluation should consider available scientific literature, clinical data, and, if necessary, clinicalinvestigations.•The manufacturer should provide sufficient clinical evidence to support the claimed performance andindications for use of the device.•The clinical evaluation should be documented and available for review by regulatory authorities.ConclusionMeeting the basic requirements for safety and effectiveness is crucial for ensuring high-quality IVD medical devices.Manufacturers should carefully consider these requirements throughout the design, development, manufacturing, and post-market phases of the device’s lifecycle. Adhering to these requirements not only ensures compliance with regulatory standards but also helps protect the health and well-being of patients and users.Note: This checklist serves as a general guide, and manufacturers should refer to specific regulatory requirements and standards applicable to their region or intended market.。
因为有了因为,所以有了所以,既然已成既然,何必再说何必
因为有了因为,所以有了所以,既然已成既然,何必再说何必|_~吾尝终日而思矣，不如须臾之所学也;吾尝而望矣，不如登高之博见也。
,,《荀子?劝学》因为有了因为，所以有了所以，既然已成既然，何必再说何必。
1.明明人在线，明明想说话，还要学隐身,明明很难过，明明很想哭，还要裂嘴笑,明明很孤单，明明很害怕，还要一个人,明明想见面，明明很期待，还要去拒绝,明明心很乱，明明想人陪，还要装沉默,明明舍不得，明明放不下，还要去放手,明明在心里，明明很在乎，还要无所谓,2.爱情其实是一种习惯，你习惯生活中有他，他习惯生活中有你。
拥有的时候不觉得什么，一旦失去，却仿佛失去了所有。
3.想你是一件快樂的事,愛你是我永遠要做的事,照顧你是我一直在做的事,不過，欺騙你是正在發生的事你收過這樣的短訊嗎,4.不喊痛，不一定没感觉。
不要求，不一定没期待。
不落泪，不一定没伤痕。
不说话，不一定没心声 ------沉默，不代表自己没话说。
离开，不代表自己很潇洒。
快乐，不代表自己没伤心。
幸福，不代表自己没痛过 rotary master common neurological disease pathogenesis, clinical manifestations, diagnosis (localized and qualitative diagnosis), differential diagnosis and therapeutic principle.2. basic requirements (1) number of diseases and cases: the number of disease cases (?) 20 30 cerebral hemorrhage cerebral infarction after subarachnoid hemorrhage: report of 5 5 of encephalitis meningitis in 510 10 3 migraines Parkinson's disease epilepsy sclerosis multiplex more than 5 2 spinal disease Guillain-Barre (Guillain-Barre) syndrome in 10 single neuropathy or multiple weeks Surrounding nerve 5 (2) basic skills required: name cases (?) standard full neurological physical examinations and locate 60 waist size 10 reading 20 EMG-EEG reading 20 skull and spinal CT reading 80 head and spine MRI reading 80 Department of Neurology ... (2) clinical knowledge and high skills: basic standards on the basis of further a high standard of inflammatory and degenerative diseases of the nervous system in pathogenesis, clinical presentation, diagnosis, differential diagnosis and therapeutic principle. Familiar with common neurological diseases such as encephalitis, epilepsy, EEG; grasp the imaging of inflammation and degeneration of the nervous system, as well as the results of Transcranial Doppler examination of clinical significance. (3) foreign language, teaching, research and other requirements: can read professional foreign language documents and perform simple medical English5.寻.迷——在寻找的过程中，偶尔迷失，偶尔犹豫，偶尔糊涂……胡来，离开，亦或坚定，皆事事有因，而非命中注定6.单身意味着你足够坚强，有足够耐心去等待那个值得拥有你的人。
欧盟GMP Part I - Basic Requirements for Medicinal Products 第一卷第七章vol4-chap7_2012-06_en
Ref. Ares(2012)778531 - 28/06/2012 EUROPEAN COMMISSIONHEALTH AND CONSUMERS DIRECTORATE-GENERALHealth Systems and ProductsMedicinal Products - Quality, safety and efficacyBrussels,SANCO/AM/sl/ddg1.d.6(2012)860362EudraLexThe Rules Governing Medicinal Products in the European UnionVolume 4EU Guidelines forGood Manufacturing Practice forMedicinal Products for Human and Veterinary UseChapter 7Outsourced ActivitiesLegal basis for publishing the detailed guidelines: Article 47 of Directive2001/83/EC on the Community code relating to medicinal products for human use andArticle 51 of Directive 2001/82/EC on the Community code relating to veterinary medicinal products. This document provides guidance for the interpretation of the principles and guidelines of good manufacturing practice (GMP) for medicinalproducts as laid down in Directive 2003/94/EC for medicinal products for human useand Directive 91/412/EEC for veterinary use.Status of the document: revision 1Reasons for changes: In view of the ICH Q10 guideline on the PharmaceuticalQuality System, Chapter 7 of the GMP Guide has been revised in order to provideupdated guidance on outsourced GMP regulated activities beyond the current scope ofcontract manufacture and analysis operations. The title of the Chapter has beenchanged to reflect this.Deadline for coming into operation: 31 January 2013Commission Européenne, B-1049 Bruxelles / Europese Commissie, B-1049 Brussel – Belgium. Telephone: (32-2) 299 11 11 PrincipleAny activity covered by the GMP Guide that is outsourced should be appropriately defined, agreed and controlled in order to avoid misunderstandings which could result in a product or operation of unsatisfactory quality. There must be a written Contract between the Contract Giver and the Contract Acceptor which clearly establishes the duties of each party. The Quality Management System of the Contract Giver must clearly state the way that the Qualified Person certifying each batch of product for release exercises his full responsibility.Note: This Chapter deals with the responsibilities of manufacturers towards the Competent Authorities of the Member States with respect to the granting of marketing and manufacturing authorizations. It is not intended in any way to affect the respective liability of Contract Acceptors and Contract Givers to consumers; this is governed by other provisions of Community and national law.General7.1 There should be a written Contract covering the outsourced activities, theproducts or operations to which they are related, and any technical arrangements made in connection with it.7.2 All arrangements for the outsourced activities including any proposed changesin technical or other arrangements should be in accordance with regulations in force, and the Marketing Authorisation for the product concerned, where applicable.7.3 Where the marketing authorization holder and the manufacturer are not thesame, appropriate arrangements should be in place, taking into account the principles described in this chapter.The Contract Giver7.4 The pharmaceutical quality system of the Contract Giver should include thecontrol and review of any outsourced activities. The Contract Giver is ultimately responsible to ensure processes are in place to assure the control of outsourced activities. These processes should incorporate quality risk management principles and notably include:7.5 Prior to outsourcing activities, the Contract Giver is responsible for assessingthe legality, suitability and the competence of the Contract Acceptor to carry out successfully the outsourced activities. The Contract Giver is also responsible for ensuring by means of the Contract that the principles and guidelines of GMP as interpreted in this Guide are followed.7.6 The Contract Giver should provide the Contract Acceptor with all theinformation and knowledge necessary to carry out the contracted operations correctly in accordance with regulations in force, and the Marketing Authorisation for the product concerned. The Contract Giver should ensure that the Contract Acceptor isfully aware of any problems associated with the product or the work which might pose a hazard to his premises, equipment, personnel, other materials or other products.7.7 The Contract Giver should monitor and review the performance of the Contract Acceptor and the identification and implementation of any needed improvement.7.8 The Contract Giver should be responsible for reviewing and assessing the records and the results related to the outsourced activities. He should also ensure, either by himself, or based on the confirmation of the Contract Acceptor’s Qualified Person, that all products and materials delivered to him by the Contract Acceptor have been processed in accordance with GMP and the marketing authorisation.The Contract Acceptor7.9 The Contract Acceptor must be able to carry out satisfactorily the work ordered by the Contract Giver such as having adequate premises, equipment, knowledge, experience, and competent personnel.7.10 The Contract Acceptor should ensure that all products, materials and knowledge delivered to him are suitable for their intended purpose.7.11 The Contract Acceptor should not subcontract to a third party any of the work entrusted to him under the Contract without the Contract Giver’s prior evaluation and approval of the arrangements. Arrangements made between the Contract Acceptor and any third party should ensure that information and knowledge, including those from assessments of the suitability of the third party, are made available in the same way as between the original Contract Giver and Contract Acceptor.7.12 The Contract Acceptor should not make unauthorized changes, outside the terms of the Contract, which may adversely affect the quality of the outsourced activities for the Contract Giver.7.13 The Contract Acceptor should understand that outsourced activities, including contract analysis, may be subject to inspection by the competent authorities.The Contract7.14 A Contract should be drawn up between the Contract Giver and the Contract Acceptor which specifies their respective responsibilities and communication processes relating to the outsourced activities. Technical aspects of the Contract should be drawn up by competent persons suitably knowledgeable in related outsourced activities and Good Manufacturing Practice. All arrangements for outsourced activities must be in accordance with regulations in force and the Marketing Authorisation for the product concerned and agreed by both parties.7.15 The Contract should describe clearly who undertakes each step of the outsourced activity, e.g. knowledge management, technology transfer, supply chain, subcontracting, quality and purchasing of materials, testing and releasing materials,undertaking production and quality controls (including in-process controls, sampling and analysis).7.16 All records related to the outsourced activities, e.g. manufacturing, analytical and distribution records, and reference samples, should be kept by, or be available to, the Contract Giver. Any records relevant to assessing the quality of a product in the event of complaints or a suspected defect or to investigating in the case of a suspected falsified product must be accessible and specified in the relevant procedures of the Contract Giver.7.17 The Contract should permit the Contract Giver to audit outsourced activities, performed by the Contract Acceptor or his mutually agreed subcontractors。
ISTA 包装测试标准介绍(英文)
ISTA 包装测试标准介绍（英文）ISTA 1 Series: Non-Simulation Integrity Performance Tests. Challenge the strength and robustness of the product and package combination. Not designed to simulate environmental occurrences. Useful as screening tests, particularly when used as a consistent benchmark over time.• Procedure 1A:Packaged-Products weighing 150 lb (68 kg) or LessBasic Requirements: fixed displacement vibration and shock testing.• Procedure 1B: Packaged-Products weighing Over 150 lb (68 kg)Basic Requirements: fixed displacement vibration and shock testing.• Procedure 1C:Extended Testing for Individual Packaged-Products weighing 150 lb (68 kg) or LessBasic Requirements: fixed displacement or random vibration, shock testing and compression.• Procedure 1D:Extended Testing for Individual Packaged-Products weighing Over 150 lb (68 kg)Basic Requirements: fixed displacement or random vibration, shock testing and compression.• Procedure 1E:Unitized LoadsBasic Requirements: vertical linear or random vibration and shock testing.• Procedure 1G:Packaged-Products weighing 150 lb (68 kg) or Less (Random Vibration)Basic Requirements: random vibration and shock testing.• Procedure 1H: Packaged-Products weighing Over 150 lb (68 kg) (Random Vibration)Basic Requirements: random vibration and shock testing.ISTA 2 Series: Partial Simulation Performance Tests. Tests with at least one element of a 3 Series type General Simulation performance test, such as atmospheric conditioning or mode-shaped random vibration, in addition to basic elements of a 1 Series type Non-Simulation Integrity test.• Procedure 2A:Packaged-Products weighing 150 lb (68 kg) or Less Basic Requirements: atmospheric conditioning, compression, fixed displacement or random vibration and shock testing.• Procedure 2B:Packaged-Products weighing over 150 lb (68 kg)Basic Requirements: atmospheric conditioning, compression, fixed displacement or random vibration and shock testing.• Procedure 2C:Furniture PackagesBasic Requirements: atmospheric conditioning, compression and shock testing.• Procedure 2D: Packaged-Products Considered FlatBasic Requirements: fixed displacement vibration and shock testing.• Procedure 2E: Packaged-Products Considered ElongatedBasic Requirements: fixed displacement vibration and shock testing.ISTA 3 Series: General Simulation Performance Tests.Designed to provide a laboratory simulation of the damage-producing motions, forces, conditions, and sequences of transport environments. Applicable across broad sets of circumstances, such as a variety of vehicle types and routes, or a varying number of handling exposures. Characteristics will include simple shaped random vibration, different drop heights applied to the sample package, and/or atmospheric conditioning such as tropical wet or winter/frozen.• Procedure 3A: Packaged-Products for Parcel Delivery System Shipments 70kg (150 lb) or Less (standard, small, flat or elongated)Test Procedure 3A is a general simulation test for individual packaged-products shipped through a parcel delivery system. The test isappropriate for four different package types commonly distributed as individual packages, either by air or ground. The types include standard, small, flat and elongated packages. Basic Requirements: atmospheric pre-conditioning, random vibration with and without top load, and shock testing.NOTE: Effective 2006, Procedure 3A has supersededProcedures 3C (Packaged Products... for Parcel Delivery SystemShipments) and 3D (Small Packaged-Products Bagged for ParcelDelivery System Shipment). 3A encompases and updates bothof these previous Procedures. Former users of 3C and 3D arenow encouraged to use 3A.• Procedure 3E:Unitized Loads of Same ProductBasic Requirements: atmospheric conditioning, compression, random vibration and shock testing.• Procedure 3F:Packaged Products for Distribution Center to Retail Outlet Shipment 100 lb (45 kg)Basic Requirements: atmospheric conditioning, compression, random vibration and shock testing.• Procedure 3H: Performance Test for Products or Packaged-Products in Mechanically Handled Bulk Transport ContainersBasic Requirements: atmospheric conditioning, random vibration and shock testing.ISTA 4 Series: Enhanced Simulation Performance Tests. General Simulation test with at least one element of focused simulation, such as test sequence or condition linked to actual known distribution. Project 4AB, an Enhanced Simulation Performance Test, is currently under development by ISTA. It will closely tie the tests and sequence to a user-defined pattern of distribution, and will include a broad range of current and quantitative information on distribution environment hazards. So the Focused Simulation elements are test-tailoring to individual situations, and usage of up-to-date and specific hazard profiles and parameters. Project 4AB willbe a web-based application to generate customized test plans; most of the complexity will be handled "behind the scenes" without burdening the user.ISTA 5 Series: Focused Simulation Performance Tests. Designed to provide a laboratory simulation based on actual field-measured and observed hazards and levels. Measured hazards will typically include complex shaped random vibration, multi-tiered drop height distribution, temperature and humidity extremes and/or cycling, and dynamic or static compressive loads. 5 Series are not performance tests per se, but Guides to the creation of Focused Simulation user-defined tests.• Guide 5B:Focused Simulation Guide for Thermal Performance Testing of Temperature Controlled Transport PackagingISTA 7 Series: Development Tests. These tests are used in the development of transport packages. They can be used to compare relative performance of two or more container designs, but are not intended to evaluate the protection afforded packaged-products.• Project 7A: Open Reusable Transport Containers for Loads of 60 lb (27 kg) or Less and Unitized for Shipment on a PalletBasic Requirements: compression and shock testing.• Procedure 7B:Closed Reusable Transport Containers for Loads of 150 lb (68 kg) or LessBasic Requirements: fixed displacement or random vibration, shock testing, compression and atmospheric pre-conditioning.• Procedure 7C:Reusable Intermediate Bulk ContainersBasic Requirements: atmospheric conditioning, compression, random vibration and shock testing.• Procedure 7D: Thermal Controlled Transport Packaging for Parcel Delivery System ShipmentBasic Requirements: atmospheric conditioning, vibration and shock testing.。
sedex等级分类
sedex等级分类Sedex等级分类一、Sedex简介Sedex（Supplier Ethical Data Exchange）是全球领先的供应链透明和可持续发展解决方案供应商。
Sedex的使命是通过促进透明度、合规性和道德商业行为，推动全球供应链的可持续发展。
为了帮助企业实现这一目标，Sedex开发了一套等级分类系统，以评估供应商的道德和社会责任表现。
二、Sedex等级分类根据Sedex的等级分类系统，供应商可以被分为四个等级：基本要求（Basic Requirements）、进一步要求（Intermediate Requirements）、高级要求（Advanced Requirements）和卓越要求（Excellence Requirements）。
下面将对每个等级的要求进行详细介绍。
1. 基本要求（Basic Requirements）基本要求是所有供应商必须满足的最低标准，以确保其符合最基本的道德和社会责任要求。
供应商需要提供基本的公司信息，如法定名称、注册地址等。
此外，供应商还需要提供员工人数、员工性别比例、工作时间、工资标准等相关信息。
基本要求还包括禁止童工和强迫劳动，确保工作场所的安全和卫生条件，以及遵守环境保护法规。
2. 进一步要求（Intermediate Requirements）进一步要求是在基本要求的基础上，对供应商的管理体系和绩效进行更详细的要求。
供应商需要提供组织结构、管理人员信息以及相关政策文件，如员工权益保障政策、环境管理政策等。
此外，供应商还需要进行内部审核，确保其管理体系的有效性和合规性。
进一步要求还包括对供应商的风险评估和改进计划的要求，以确保其能够持续改进并符合更高的要求。
3. 高级要求（Advanced Requirements）高级要求是对供应商在社会责任和可持续发展方面更高水平要求的等级。
供应商需要提供更详细的信息，如员工培训计划、供应链管理计划等。
售后服务承诺书 英文
售后服务承诺书英文1. Basic requirements of our after-sale service 1) If any quality problems such as design, manufacture, function or procedure occur within the guarantee period, SCCW shall take full responsibility and bear all the economic losses incurred.2) If any quality problems occurs within the guarantee period, SCCW shall provide on-siteservice after receive the buyer’s notice in 24 hrs.3) If any big quality problems occurs out of the guarantee period, SCCW will send maintenancetechnician to provide visiting service after receive the buyer’s notice in 24 hrs and charge fora favorable price.4) SCCW will provide a lifetime favorable price to the buyer with the materials and spare partsused in system operation, equipment maintenance. The above mentioned are only basic after-sale service requirements, we will make more promises related to quality assurance and operation guarantee mechanism.2. After-sale service commitment1) Quality and service commitment :After-sale service department:SCCW will set up a after-sale service department and spare parts center specified for Valin ArcelorMittal Automotive Steel Co.,Ltd Crane in Main Factory Building of Cold Rolling Project and provide professional equipment maintenance engineers.Payment of maintenance expense:All the maintenance expense within the guarantee period shall be borne by SCCW.After-sale service measures within the guarantee periodThe after-sale service work is an important part of our marketing and sales work. The quality of service provided will not only influence the company credit, but also closely relate to the safely running of the equipments. In order to maintain the good reputation of Hercules, SCCW will strictly observe relevant national regulations about Product-Quality Law and provide high quality products with the principle of hospitable reception, enthusiastic service, quickresponse and prompt resolution. We will conscientiously implement the after-sale service work in full-scale, and make commitment to our clients as follows:1. Select and appoint engineering technicians and workers who are professionallycompetent and personally committed to undertake the after-sale service work. Meanwhile set up the service office made up of chief engineer office, project office, technical center, after-sale service department and workshop specialists led and coordinated by marketing and sales department.2. During the Valin ArcelorMittal Automotive Steel Co.,Ltd Crane in Main FactoryBuilding of Cold Rolling Project on-site installation and trial un, appoint specialized after-sale service personnel to work at the work place 售后服务承诺书英文 [篇2]范本1售后服务承诺书凡购买我公司产品保修壹年，在质保期内出现质量问题，本公司免费维修，终身提供技术支持及配件。
- 1、下载文档前请自行甄别文档内容的完整性，平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益，请联系客服反馈,我们会尽快为您处理(人工客服工作时间：9:00-18:30)。
The Uniform Requirements for Manuscripts Submitted to Biomedical Journals
1．Title（标题） 2．Abstract（摘要） 3．Introduction（引言） 4．Materials and Methods（材料与方法） 5．Results（结果） 6．Discussion（讨论） 7．Acknowledgements（致谢）* 8．References（参考文献） 9．Legends（插图说明） * 10．Figures（插图） * 11．Tables（表格）* 12．Plates and Explanations（照片说明） *
As is well known, AIDS is one of the most dangerous epidemics. It spreads and menaces the life and healthy of the people through the world. To this day, about 20 millions people died of AIDS and 42 millions people are infected by HIV virus. But AIDS is still spreading and millions of people are infected every year. So many people only have twenty kinds of clinical drugs to use. Though these drugs can inhibit the copy of HIV virus, drug resistance is a key cause of failure for treatment of HIV infection. So it is a hot point to find out new drugs with new structure and new anti-HIV mechanism and it is supported by many governments.
Passive We immersed the samples in an ultrasonic bath for 3 minutes in acetone followed by 10 minutes in distilled water. (X)
The samples were immersed in an ultrasonic bath for 3 minutes in acetone followed by 10minutes in distilled water. (√)
Tense 时态
Past tense This study investigated... (abstract) The work was carried out on the Imperial College gas atomizer. (materials and methods) After flights of less than two hours, 11% of the army pilots and 33% of the civilian pilots reported back pain. (results) In the first series of trials, the experimental values were all lower than the theoretical predictions. (discussion)
• As is well known, AIDS is one of the most dangerous epidemics. It spreads and menaces the life and healthy of the people through the world. • As is well known, AIDS is one of the most dangerous epidemics. It has been spreading and menacing people’s health and lives throughout the world. • As is well known, AIDS is one of the most dangerous epidemics which have/has been spreading … • As is well known, AIDS, one of the most dangerous epidemics, has been spreading and menacing people’s health and lives throughout the world. √
Voice 语态
• menthods 延用被动语态 • 适当的时候主动句表达被动的意思，如表 示目的、结论、重要贡献时，the paper presents
Voice 语态
Active For the second trial, the apparatus was covered by a sheet of plastic. It was believed that this modification would reduce the amount of scattering. (X)
Voice 语态
Active In summary, previous methods are all extremely inefficient. Hence a new approach is developed to process the data more efficiently. (X) This paper presents a new approach that processes the data more efficiently. (√)
English Paper Writing
Your personal reasons for publishing
Rejection?
* International Committee of Medical Journal Editors (ICMJE） 国际医学期刊编辑委员会 * Uniform Requirements for Manuscripts Submitted to Biomedical Journals 《生物医学期刊投稿的统一要求》
Tense 时态
present tense
This paper presents … (abstract) We describe a new molecular approach to analyzing ... (abstract) Little literature is available on X (introduction) A twin-lens reflex camera is actually a combination of two separate camera boxes. (materials and methods)只有表示陈述事实才可用现在时 Figure 2 shows the variation in the temperature of the samples over time. (results)使用现在时表示肯定，过去时表示对结论不确定 These results agree well with the findings of Smith, et al. (results) The data reported here suggest that the reaction rate may be determined by the amount of oxygen available. (discussion)
present past, perfect
present, past past
Results Discussion
Data, effects and properties Analysis, comparison, recommendations and predictions
past；shows present, past should can/could may/might
• To this day, about 20 millions people died of AIDS and 42 millions people are infected by HIV virus. But AIDS is still spreading and millions of people are infected every year. • To this day, about 20 million people have died of AIDS, and 42 million have been infected with HIV. And AIDS is still spreading and millions more people are infected every year. • To this day, about 20 million people have died of AIDS, and 42 million have been infected with HIV. And millions more people are infected every year. • About 20 million people have died of AIDS, 42 million have been infected with HIV, and millions more are infected every year. √